Target intelligence / Profile preview

Hemagglutinin Protein of Influenza A Virus Subtype H5 (HA (H5))

Target
HA (H5)
Molecular classification
Viral protein, Glycoprotein, Membrane protein, Hemagglutinin
01

Overview

Hemagglutinin (HA) is a trimeric glycoprotein on the surface of influenza A viruses, including subtype H5. It mediates viral infectivity by attaching to host cells via sialic acid binding and facilitating fusion of the viral envelope with the host cell membrane. HA exists as a homotrimer composed of HA1 and HA2 subunits. The globular head domain (HA1) contains the receptor-binding site and is the primary target for neutralizing antibodies. The stem domain (HA2) anchors the protein in the viral membrane and mediates membrane fusion. H5 belongs to group 1 hemagglutinins. Highly pathogenic avian influenza A(H5N1) can infect humans, and mutations in hemagglutinin can alter receptor specificity, potentially increasing human transmissibility. The HA gene resides on one segment of influenza A's RNA genome. Mutations near cleavage sites or receptor-binding domains can affect virulence, transmissibility, and vaccine effectiveness.

Other names
H5 hemagglutininInfluenza A H5 hemagglutininHA protein (H5 subtype)
02

Mechanism of action

Entry inhibition (targeted by neutralizing antibodies)

03

Biological functions

Receptor binding (sialic acid)Membrane fusionViral entryHost cell attachmentRed blood cell agglutination
04

Disease associations

InfectionInfluenzaAvian influenzaZoonotic disease
05

Safety considerations

Antigenic driftAntigenic shiftZoonotic transmissionReceptor specificity changes (leading to increased human transmissibility)Increased virulence

Beyond the preview

Go deeper on Hemagglutinin Protein of Influenza A Virus Subtype H5 (HA (H5)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemagglutinin Protein of Influenza A Virus Subtype H5 (HA (H5)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call